Orsiro™ Drug Eluting Stent in Routine Clinical Practice
NCT02039739 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1007
Last updated 2023-06-28
Summary
The purpose of this study is to evaluate effectiveness and safety of Orsiro™ Drug Eluting Stent in Routine Clinical Practice
Conditions
- Angioplasty, Transluminal, Percutaneous Coronary
- Coronary Artery Disease
Interventions
- DEVICE
-
Orsiro™ Drug Eluting Stent group
Sponsors & Collaborators
-
CardioVascular Research Foundation, Korea
collaborator OTHER -
Biotronik Korea Co., Ltd
collaborator INDUSTRY -
Seung-Jung Park
lead OTHER
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-06-30
- Primary Completion
- 2017-08-31
- Completion
- 2022-01-31
Countries
- South Korea
Study Locations
More Related Trials
-
Clinical Impact of Orsiro™ Stent in Patient With Chronic Kidney Disease
NCT06475625 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
BIOTRONIK Orsiro Pre-Marketing Registration
NCT02870985 ·Status: COMPLETED ·Phase: NA
-
DESyne in Routine Clinical Practice
NCT02039713 ·Status: TERMINATED
-
Sirolimus Eluting ORSIRO Stent Versus Biolimus-eluting NOBORI Stent
NCT01879358 ·Status: UNKNOWN ·Phase: NA
-
ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence Tomography
NCT01594736 ·Status: COMPLETED ·Phase: PHASE4
-
Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III (LONG-DES-III)
NCT01078038 ·Status: COMPLETED ·Phase: PHASE4
-
IRIS-Synergy Cohort in the IRIS-DES Registry
NCT02720419 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice
NCT01186133 ·Status: RECRUITING
-
Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
NCT04175626 ·Status: COMPLETED
-
Long Term Safety Profile of the PRO-Kinetic ENERGY Coronary Stent System in Daily Clinical Practice
NCT01056120 ·Status: COMPLETED
-
Evaluation of Effectiveness and Safety of XIENCE Sierra in Routine Clinical Practice
NCT03967158 ·Status: ACTIVE_NOT_RECRUITING
-
Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - Comparison of REDUCTION of PrasugrEl Dose & POLYmer TECHnology in ACS Patients (HOST REDUCE POLYTECH RCT Trial)
NCT02193971 ·Status: COMPLETED ·Phase: PHASE4
-
BIOFLOW III Satellite-Italy Orsiro Stent System
NCT02028728 ·Status: COMPLETED
-
Quantitative Coronary Angiography Versus Intravascular Ultrasound GUIDancE for Drug-Eluting Stent Implantation
NCT02978456 ·Status: COMPLETED ·Phase: NA
-
CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 4
NCT05066789 ·Status: TERMINATED ·Phase: PHASE4
-
Vascular Response of Orsiro vs. Xience Drug-Eluting Stents for Treating Coronary Bifurcation Lesions
NCT05200637 ·Status: UNKNOWN ·Phase: NA
-
A Comparison of an Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent for Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
NCT02579031 ·Status: COMPLETED ·Phase: NA
-
Serial OCT Evaluation of Tissue Coverage in Patients Submitted to Inspiron Drug Eluting Stent Implantation
NCT03269461 ·Status: COMPLETED ·Phase: NA
-
SORT OUT X - Combo Stent Versus ORSIRO Stent
NCT03216733 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
NCT00638794 ·Status: COMPLETED
-
Evaluation of Everolimus-Eluting Stents (The K-XIENCE Registry)
NCT01350869 ·Status: COMPLETED
-
Non-acute Coronary occlusIon Treated By Everolimus ELuting Stent
NCT00793221 ·Status: COMPLETED ·Phase: PHASE3
-
Optical Coherence Tomography in Long Lesions
NCT01133925 ·Status: UNKNOWN ·Phase: PHASE4
-
INSPIRON Sirolimus Eluting Stent Performance in Bifurcation Coronary Arteries Treated Using Provisional Technique
NCT03780192 ·Status: UNKNOWN
-
BIOFLOW III Satellite-ELADIS Orsiro Stent System
NCT02029092 ·Status: COMPLETED